Acoustic blood analysis platform for coagulation and bleeding risk assessment
Levisonics develops acoustic tweezing rheometry—a non-contact, drop-of-blood diagnostic technology for hemostasis and thrombotic risk assessment. The company is in active transition from laptop-based prototyping to embedded systems, evidenced by concurrent projects around portable battery design, embedded processing, and MATLAB-to-production code conversion. The senior-heavy engineering and research team (4 of 5 hires) reflects a pre-commercialization biotech profile focused on hardware maturation and software optimization for resource-constrained environments.
Levisonics is a medical device company based in Fishers, Indiana, founded in 2016. The core platform uses acoustic technology to measure blood coagulation and rheological properties from minimal sample volumes, targeting neonatal, pediatric, and adult hemostasis assessment. The technology also has applications in real-time quality control for food and liquid manufacturing. At 2–10 employees, the team is structured around engineering, research, and support functions, with active development focused on transitioning the platform from research apparatus to portable, battery-powered embedded devices suitable for clinical and industrial use.
Acoustic tweezing rheometry—a non-contact measurement method that analyzes coagulation, polymerization, and fluid viscoelasticity from a single drop of blood without physical contact.
Portable battery system design, embedded processing architecture, sample handling system improvement, and conversion of MATLAB prototypes to production embedded software for resource-constrained clinical devices.
Fishers, Indiana. The company was founded in 2016 and is privately held with a team of 2–10 employees based in the United States.
Other companies in the same industry, closest in size